Bioliance’s journey to operational excellence with innovative monitoring

Bioliance’s IT team was experiencing difficulty effectively tracking quality indicators. Each month, the team faced the arduous tasks of extracting data from MPL (middleware solution) and the Laboratory Information System (LIS) and then manually updating tables before disseminating them to the respective teams.

This time-consuming process only focused on essential indicators, limiting the scope to contractual obligations. The team wanted to implement a process that would encompass action plans and help identify the root causes behind any potential performance issues.

With its customizable dashboards for every specific case use, navify Analytics has helped Bioliance revolutionize its approach, resulting in more productive routine interactions among laboratory teams. These dashboards can be conveniently shared on a monthly basis, providing valuable insights and support to all laboratory stakeholders.

Now, whenever an opportunity for improvement arises, Bioliance’s teams can dive into navify Analytics customized dashboards to explore potential action plans in detail and closely monitor results in real time.

To ensure efficient operations, Bioliance has introduced an indicator that tracks the processing time for tubes received from its emergency departments.

Illustrated in the provided example, the Bioliance dashboard enables their team to conduct monthly evaluations based on predefined criteria outlined in their contracts with healthcare facilities. By doing so, Bioliance substantiates its dedication to delivering tubes within a 60-minute timeframe, reinforcing its commitment to timely and reliable service.

During its assessment of blood gas turnaround time, the Bioliance team identified delays that exceeded the laboratory’s set objectives. An analysis of the sequence steps revealed a significant delay (46 minutes) following test transportation and analysis. To fix this issue, the team proactively implemented an alert system that promptly notifies the biologist whenever a result awaits validation.

The implementation of this alert system yielded remarkable results, helping reduce wait time by 60%. This improvement not only ensures timely validation but also enhances overall efficiency and workflow in laboratory operations.

Bioliance closely monitors retesting rates as part of its process to continually reassess expertise rules. Additionally, they conduct annual reviews of self-validation rules to ensure their ongoing relevance and alignment with current industry standards.

In hemostasis, Bioliance observed a high manual validation rate, which it attributed to the absence of a defined automatic validation flowchart. This prompted improved collaboration among biologists from the hemostasis working group. Bioliance continues to monitor and reassess its expertise rules to improve laboratory operations.